MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody related autism.

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...

The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) announced the official launch of the world's ...

Developed in collaboration with the CUHK spin-off MicroSigX Biotech Diagnostic, the world’s first “AI-Powered Multikingdom ...

MARAbio Systems (MARAbio), a precision immunology company dedicated to detecting, treating, and preventing Maternal Autoantibody Related Autism (MARA), has commercially launched the MAR-Autism Test, ...

University to launch pilot project in January using new technology that tests stool samples and provides results as quickly ...

In The Unmasking Workbook for Autistic Adults, I wrote about the transformative power of unmasking, and I created a roadmap ...

After the government’s endorsement, many parents rushed to get their hands on leucovorin. They soon discovered that they were ...

Poorly controlled thyroid disease with persistent imbalance across trimesters is associated with an increased risk for autism ...

Access to autism evaluations through specialty health care is notorious for long wait times across the United States. In ...

The Ontario Court of Justice allowed breath test evidence under s 24 (2) of the Canadian Charter of Rights and Freedoms, ...

Autism is now the single most expensive disability in the entire $50bn per year NDIS. And autism diagnoses and funding will ...